Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention

BACKGROUND: The safety of administration of tirofiban, a platelet glycoprotein IIb/IIIa inhibitor, followed by a clopidogrel loading dose in clopidogrel-naïve patients undergoing ad-hoc percutaneous coronary intervention (PCI) is not yet clear. METHODS: In a retrospective observational cohort analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Habibi, Zarina, Luijkx, Jasper, Gho, Ben C. G., Ilhan, Mustafa, Veenstra, Leo F., Ruiters, Lex A. W., Stein, Mera, van ’t Hof, Arnoud W. J., Rasoul, Saman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602969/
https://www.ncbi.nlm.nih.gov/pubmed/37713051
http://dx.doi.org/10.1007/s12471-023-01810-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602969/
https://www.ncbi.nlm.nih.gov/pubmed/37713051
http://dx.doi.org/10.1007/s12471-023-01810-2

Ejemplares similares